Renaissance Technologies
NYMX

Renaissance Technologies’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Renaissance Technologies’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60,800
Closed -$12K – 4309
2023
Q2 		$12K Sell
60,800
-8,581
-12% -$3.38K ﹤0.01% 3821
2023
Q1 		$24K Sell
69,381
-13,419
-16% -$5.45K ﹤0.01% 3801
2022
Q4 		$27K Buy
+82,800
New +$30K ﹤0.01% 3909
2022
Q3 		– Sell
-19,742
Closed -$9K – 4529
2022
Q2 		$9K Buy
+19,742
New +$18.2K ﹤0.01% 4162
2021
Q1 		– Sell
-67,564
Closed -$168K – 3828
2020
Q4 		$168K Buy
67,564
+31,664
+88% +$70K ﹤0.01% 3175
2020
Q3 		$88K Sell
35,900
-23,475
-40% -$68.3K ﹤0.01% 3228
2020
Q2 		$211K Sell
59,375
-45,325
-43% -$143K ﹤0.01% 3143
2020
Q1 		$245K Buy
104,700
+69,019
+193% +$194K ﹤0.01% 3042
2019
Q4 		$78K Buy
35,681
+16,291
+84% +$32.1K ﹤0.01% 3349
2019
Q3 		$35K Buy
19,390
+4,490
+30% +$7.85K ﹤0.01% 3353
2019
Q2 		$22K Buy
+14,900
New +$26.1K ﹤0.01% 3493
2017
Q3 		– Sell
-54,500
Closed -$240K – 3426
2017
Q2 		$240K Buy
+54,500
New +$224K ﹤0.01% 2958
2014
Q3 		– Sell
-28,000
Closed -$139K – 2999
2014
Q2 		$139K Buy
28,000
+1,494
+6% +$7.69K ﹤0.01% 2620
2014
Q1 		$145K Sell
26,506
-16,794
-39% -$97.4K ﹤0.01% 2664
2013
Q4 		$263K Buy
43,300
+7,800
+22% +$53.2K ﹤0.01% 2536
2013
Q3 		$235K Buy
+35,500
New +$232K ﹤0.01% 2529

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Renaissance Technologies's NYMX Position: Q3 2023 in Review

Renaissance Technologies sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 60,800 shares — an estimated $12K sold.

Renaissance Technologies first reported a position in NYMX in Q3 2013 and held it in 16 quarters. The position peaked at $263K in Q4 2013. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Renaissance Technologies reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 60,800 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $12K.
  • Renaissance Technologies first reported a position in Nymox Pharmaceutical Corp in Q3 2013 and held it in 16 quarters.
  • Renaissance Technologies's Nymox Pharmaceutical Corp position peaked at $263K in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.